IRF1 and breast cancer: Suppression of IRF1 expression by IRF1 siRNAs (TCanti-IRF1, stimulated HOTAIR expression and reduced the anticancer effects of Dp, signifying that Dp interferes with the regulation of Akt/IRF1/HOTAIR signaling pathway in breast cancer (98).